期刊文献+

L-精氨酸对高糖引起内皮功能失调的保护作用 被引量:1

Effects of L-Arginine on Human Umbilical Vein Endothelial Cell Induced by High Concentration Glucose
下载PDF
导出
摘要 目的通过研究L-精氨酸和NG-硝基-L-精氨酸-甲基酯对人脐静脉内皮细胞产生一氧化氮和超氧阴离子的影响以探讨L-精氨酸对高糖引起内皮功能失调的保护作用。方法不同浓度L-精氨酸、NG-硝基-L-精氨酸-甲基酯、葡萄糖和胰岛素加入体外培养的人脐静脉内皮细胞,24 h后分别测定细胞培养液中一氧化氮合酶和超氧化物歧化酶活性及一氧化氮和超氧阴离子浓度。结果25 mmol/L葡萄糖使内皮细胞一氧化氮合酶活性增高,一氧化氮产生增加,超氧化物歧化酶活性下降,超氧阴离子产生增加;L-精氨酸对一氧化氮合酶、一氧化氮、超氧化物歧化酶的影响与对照组相比无显著性差异(P>0.05),但可以使超氧阴离子产生减少;25 mmol/L葡萄糖+L-精氨酸使内皮细胞一氧化氮合酶活性增强,一氧化氮产生增加,L-精氨酸可以改善高糖引起的超氧阴离子升高。不同浓度的胰岛素使内皮细胞一氧化氮合酶活性增高,一氧化氮产生增加,对超氧化物歧化酶活性和超氧阴离子产生无明显影响;不同浓度胰岛素+L-精氨酸使内皮细胞一氧化氮合酶活性增强,一氧化氮产生增加,对超氧化物歧化酶活性无明显影响,但可以使超氧阴离子水平降低。100μmol/L NG-硝基-L-精氨酸-甲基酯使内皮细胞一氧化氮合酶活性下降,一氧化氮产生减少,对超氧化物歧化酶活性无明显影响,但使超氧阴离子产生增加;25 mmol/L葡萄糖+NG-硝基-L-精氨酸-甲基酯使内皮细胞一氧化氮合酶活性下降,一氧化氮产生减少,但对高糖引起的超氧化物歧化酶活性下降和超氧阴离子升高无明显影响。10 mu胰岛素+10μmol/L NG-硝基-L-精氨酸-甲基酯和100 mu胰岛素+100μmol/L NG-硝基-L-精氨酸-甲基酯使内皮细胞一氧化氮合酶活性下降,一氧化氮产生减少,对超氧化物歧化酶活性无明显影响,但使超氧阴离子升高。结论L-精氨酸对一氧化氮合酶、一氧化氮、超氧化物歧化酶无明显影响,但可以使超氧阴离子产生减少;NG-硝基-L-精氨酸-甲基酯使内皮细胞一氧化氮合酶活性下降,一氧化氮产生减少,对超氧化物歧化酶活性无明显影响,但使超氧阴离子产生增加。 Aim To investigate effects of L-arginine and N^G-nitro-L-arginine methyl ester (L-NAME) on human umbilical vein endothelial cell ( hUVEC ) secreting nitric oxide (NO) and superoxide anion ( O2^- ). Methods hUVEC was incubated with glucose, insulin, L-arginine and L-NAME respectively for 24 hours. The activity of nitric oxide synthase (NOS) and superoxide dismutase ( SOD ), the concentration of NO and O2 in the supernatant of cultured hUVEC was measured at the end of the experiment. Results NOS activity, the concentration of NO increased, while SOD activity decreased and the concentration of O2 increased significantly in the presence of 25 mmol/L glucose. NOS, NO, SOD did not change significantly in the presence of L-arginine, while the concentration of O2 decreased significantly. The activity of NOS, the concentration of NO increased in thepresenee of 25mmol/Lglucose+L-arginine, L-arginine may reverse the elevation of O2 which induced by glucose. NOS, NO increased in the presence of 10, 100, 1 000 mu/L insulin, while SOD and O2 did not change significantly. NOS, NO increased in the presence of L-arginine + insulin, SOD activity did not change significantly while O2^- decreased. NOS activity and the generation of NO decreased in the presence of 100μmol/L L-NAME, while SOD activity did not change signiticanfly, however the. generation of O2 increased. NOS, NO decreased in the presence of 25 mmol/L glucose + L-NAME, however SOD activity and the concentration of O2 did not change significantly. NOS, NO decreased in the presence of 10 mu insulin + 10μmmol/L L-NAME and 100 mu insulin+ 100μmol/L L-NAME, SOD activity did not change significantly, while the concentration of O2 increased. Conclusion NOS, NO, SOD did not change significantly while O2 decreased in the presence of L-arginine. NOS activity, the generation of NO decreased while O2^- increased in the presence of L-NAME in the supematant of cultured endothelial cell.
出处 《中国动脉硬化杂志》 CAS CSCD 2005年第6期725-728,共4页 Chinese Journal of Arteriosclerosis
关键词 细胞生物学 L-精氨酸对内皮功能的保护作用 胶原酶消化法 L-广精氨酸 NG-硝基-L-精氨酸-甲基酯 一氧化氮 超氧阴离子 L-Arginine N^G-Nitro-L-Arginine Methyl Ester Nitric Oxide Superoxide Anion Human Umbilical Vein Endothelial Cell Endothelial Function
  • 相关文献

参考文献9

  • 1Wever RMF,Lüscher TF,Cosentino F,Rabelink TJ.Atherosclerosis and the two faces of endothelial nitric oxide synthase.Circulation,1998,97 (1):108-112
  • 2(A)ngg(a)rd E.Nitric oxide:mediator,murderer,and medicine.Lancet,1994,343 (8906):1 199-206
  • 3Sun YP,Zhu BQ,Browne AEM,Gao LR,Chou TM,Sudhir CK.L-arginine decreases blood pressure and left ventricular hypertrophy in rats with experimental aortic coarctation.J Am Coll Cardiol,1998,31 (Suppl A):501A
  • 4Preli RB,Klein KP,Herrington DM.Vascular effects of dietary L-arginine supplementation.Atherosclerosis,2002,162 (1):1-15
  • 5姚瑞,党瑜华,张菲斐.非对称性二甲基精氨酸对人脐静脉内皮细胞功能的影响[J].中国动脉硬化杂志,2005,13(4):471-474. 被引量:6
  • 6Ortiz PA,Garvin JL.Interaction of O2-and NO in the thick ascending limb.Hypertension,2002,39 (2):591-596
  • 7桂新春,刘宗汉,刘江华,戴忠,谢志忠,许金华,张楚君.葡萄糖对血管内皮细胞小凹蛋白1和血管内皮生长因子表达的影响[J].中国动脉硬化杂志,2004,12(1):38-42. 被引量:7
  • 8Guzik TJ,West NEJ,Pillai R,Taggart DP,Channon KM.Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels.Hypertension,2002,39 (6):1 088-094
  • 9Casanello P,Sobrevia L.Intrauterine growth retardation is associated with reduced activity and expression of the cationic amino acid transport systems y+/hCAT-1 and y+/hCAT-2B,and lower activity of nitric oxide synthase in human umbilical vein endothelial cells.Circ Res,2002,91 (2):127-134

二级参考文献29

  • 1Boger RH, Bode-Boger SM. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway and cardiovascular disease. Semin Thromb Hemost, 2000, 26 (5): 539-545.
  • 2Andrew JM. Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases. Nitric Oxide: Biology and Chemistry, 2002, 6 (2): 101-124.
  • 3Verma S, Anderson TJ. Fundamental of endothelial function for the clinical cardiologist. Circulation, 2002, 105 (5): 546-549.
  • 4Vallance P, Leiper J. Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol, 2004, 24 (6): 1 023-030.
  • 5Tsikas D, Boger RH, Sandmamm J, Stefanie M, Bode-Boger, Frolich JC. Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox. FEBS Lett, 2000, 478 (1-2): 1-3.
  • 6Mcdmald Kk, Zharikov S, Block ER. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric oxide synthase may explain the 'L-arginine paradox'. Bio Chem, 1997, 272 (10): 31 213-216.
  • 7Hornig B, Drexler H. Reversal of endothelial dysfunction in humans. Coron Artery Dis, 2001, 12 (6): 463-473.
  • 8Boger RH. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res, 59 (4): 824-833.
  • 9Piatti P, Fragasso G, Monti L, Lucilla D, Setola E, Lucotti P, et al. Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves arteriograms: correlation with asymmetric dimethylarginine levels. Circulation, 2003, 107 (3): 429-436.
  • 10John P. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol, 2000, 20 (9): 2 032-037

共引文献11

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部